Comparative Pharmacology
Head-to-head clinical analysis: COMBOGESIC IV versus COMPOUND 65.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COMBOGESIC IV versus COMPOUND 65.
COMBOGESIC IV vs COMPOUND 65
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of acetaminophen (paracetamol) and ibuprofen. Acetaminophen: Weak COX inhibition in CNS, analgesic and antipyretic. Ibuprofen: Non-selective COX-1/COX-2 inhibition, anti-inflammatory, analgesic, antipyretic.
COMPOUND 65 acts as a selective serotonin reuptake inhibitor (SSRI), increasing serotonin levels in the synaptic cleft by blocking the serotonin transporter (SERT).
1 vial (1000 mg paracetamol + 60 mg codeine phosphate) IV infusion over 15 minutes, every 4-6 hours as needed, max 4 vials per day.
25 mg orally every 8 hours as needed for pain; maximum 75 mg per day.
None Documented
None Documented
Paracetamol: 1.5-3 hours; tramadol: 6 hours (active metabolite M1: 7-9 hours). Clinical context: Extended half-life in hepatic impairment (cirrhosis) and elderly; requires dose adjustment.
Terminal elimination half-life is 8-12 hours in healthy adults; prolonged to 15-20 hours in hepatic impairment; requires dose adjustment in severe hepatic disease.
Renal: 90% as glucuronide conjugates and unchanged drug for paracetamol; biliary: 10% for paracetamol. For tramadol: renal 90% (unchanged and metabolites), fecal 10%.
Renal excretion of unchanged drug accounts for 30-40%; hepatic metabolism with fecal elimination of metabolites accounts for 50-60%; biliary excretion is minimal (<5%).
Category C
Category C
Analgesic Combination (Opioid + Non-Opioid)
Analgesic Combination (Opioid + NSAID)